Duality Biotherapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul '26 Jul 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	18,465	26,664	-	-
Enterprise Value	14,870	22,676	-	-
Last Close Price	204.20	298.20	-	-
PS Ratio	8.96	12.94	-	-
PB Ratio	6.84	9.87	-	-
P/TBV Ratio	6.85	9.89	-	-
P/FCF Ratio	90.63	130.88	-	-
P/OCF Ratio	85.28	123.14	-	-
EV/Sales Ratio	7.22	11.00	-	-
EV/FCF Ratio	72.99	111.30	-	-
Debt / Equity Ratio	0.06	0.06	0.00	0.00
Debt / EBITDA Ratio	-	-	-	0.01
Debt / FCF Ratio	0.82	0.82	0.02	0.01
Net Debt / Equity Ratio	-1.33	-1.33	0.69	1.01
Net Debt / EBITDA Ratio	7.14	7.14	7.63	-1.53
Net Debt / FCF Ratio	-17.64	-17.64	-4.94	-1.40
Asset Turnover	0.62	0.62	1.08	-
Quick Ratio	3.52	3.52	0.48	0.50
Current Ratio	3.65	3.65	0.49	0.52
Return on Equity (ROE)	-1282.14%	-1282.14%	-	-
Return on Assets (ROA)	-9.61%	-9.61%	-6.51%	-
Return on Capital Employed (ROCE)	-16.20%	-16.20%	10.50%	-69.40%
Earnings Yield	-15.64%	-10.83%	-	-
FCF Yield	1.10%	0.76%	-	-
Buyback Yield / Dilution	-714.45%	-714.45%	-	-